Cary Street Partners Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Sell |
551
-203
| -27% | -$82.3K | 0.11% | 211 |
|
|
2025
Q1 | $375K | Buy |
754
+2
| +0.3% | +$995 | 0.22% | 117 |
|
|
2024
Q4 | $391K | Sell |
752
-31,514
| -98% | -$16.4M | 0.26% | 101 |
|
|
2024
Q3 | $20M | Buy |
32,266
+1,538
| +5% | +$951K | 0.74% | 29 |
|
|
2024
Q2 | $17M | Buy |
30,728
+562
| +2% | +$311K | 0.69% | 32 |
|
|
2024
Q1 | $17.5M | Buy |
30,166
+412
| +1% | +$239K | 0.74% | 27 |
|
|
2023
Q4 | $15.8M | Buy |
29,754
+1,886
| +7% | +$1M | 0.75% | 29 |
|
|
2023
Q3 | $14.1M | Buy |
27,868
+3,886
| +16% | +$1.97M | 0.76% | 25 |
|
|
2023
Q2 | $12.5M | Sell |
23,982
-654
| -3% | -$341K | 0.8% | 24 |
|
|
2023
Q1 | $14.2M | Sell |
24,636
-6
| -0% | -$3.46K | 1.02% | 16 |
|
|
2022
Q4 | $13.6M | Sell |
24,642
-353
| -1% | -$194K | 1% | 17 |
|
|
2022
Q3 | $12.7M | Buy |
24,995
+1,711
| +7% | +$868K | 1.04% | 21 |
|
|
2022
Q2 | $12.7M | Buy |
23,284
+14,671
| +170% | +$7.97M | 1.07% | 19 |
|
|
2022
Q1 | $5.09M | Sell |
8,613
-53
| -0.6% | -$31.3K | 1.4% | 13 |
|
|
2021
Q4 | $5.78M | Buy |
8,666
+107
| +1% | +$71.4K | 1.6% | 11 |
|
|
2021
Q3 | $4.89M | Sell |
8,559
-531
| -6% | -$303K | 1.6% | 12 |
|
|
2021
Q2 | $4.59M | Buy |
9,090
+4,656
| +105% | +$2.35M | 1.48% | 12 |
|
|
2021
Q1 | $2.02M | Sell |
4,434
-1,093
| -20% | -$499K | 0.83% | 27 |
|
|
2020
Q4 | $2.57M | Sell |
5,527
-3,308
| -37% | -$1.54M | 0.5% | 48 |
|
|
2020
Q3 | $3.9M | Buy |
+8,835
| New | +$3.9M | 0.83% | 33 |
|